Related Experiment Video
Updated: Feb 27, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.5K
[Update in HIV therapy: tenofovir alafenamide]
Anne-Sophie Sauvage1, Gilles Darcis1, Michel Moutschen1
1Service de médecine interne générale et de maladies infectieuses, Université de Liège, Centre hospitalier universitaire (CHU) de Liège, Domaine universitaire du Sart-Tilman, 4000 Liège, Belgique.
Revue Medicale Suisse
|July 4, 2017
Summary
Tenofovir alafenamide (TAF) offers improved safety for HIV patients compared to tenofovir disoproxil fumarate (TDF). TAF reduces risks of kidney damage and bone density loss, enhancing treatment outcomes.
Area of Science:
- Antiviral drug development
- Pharmacology
- HIV/AIDS therapeutics
Background:
- Since 1987, significant advancements have been made in human immunodeficiency virus (HIV) treatments.
- While 24 molecules exist, only a subset is widely used due to administration ease and side effect profiles.
- Tenofovir disoproxil fumarate (TDF), a common nucleoside reverse-transcriptase inhibitor (NRTI), is linked to renal toxicity and bone demineralization.
Purpose of the Study:
- To evaluate the safety profile of tenofovir alafenamide (TAF) compared to TDF.
- To investigate the impact of TAF on renal and bone health in HIV patients.
Main Methods:
- Comparative analysis of drug efficacy and safety.
- Pharmacokinetic studies assessing serum and intracellular concentrations.
Main Results:
- Tenofovir alafenamide (TAF) demonstrates a more favorable safety profile regarding renal and bone complications.
- TAF achieves significantly lower serum concentrations and higher intracellular concentrations of tenofovir (TFV).
Conclusions:
- TAF represents a safer alternative to TDF for HIV treatment, particularly concerning bone and kidney health.
- The distinct pharmacokinetic properties of TAF contribute to its improved safety profile.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
50.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.0K
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
382
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
382
02:33Retroviruses
15.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.1K
01:29Subviral Agents
668
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
668
01:28Drug Therapy
327
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
327
01:29Therapeutic Drug Monitoring: Affecting Factors
288
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288